Faster Clinical Translation and Commercialization of Therapies Derived From iPSC Technology GERMANTOWN, MARYLAND / ACCESS ...
This study provides evidence that single-cell multi-omics profiling can reveal key regulators of HIV-1 persistence and early immune dysregulation, particularly implicating KLF2 and Th17 cells as major ...
Faster Clinical Translation and Commercialization of Therapies Derived From iPSC Technology GERMANTOWN, MARYLAND / ACCESS Newswire / March 4, 2025 / uBriGene Biosciences (uBriGene), a leading cell and ...
A six-month modified Atkins diet intervention in relapsing multiple sclerosis patients led to significant immunometabolic ...
Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic inflammatory disease of the central nervous system caused by the immune system. B ...
A study, which was published in January in the journal Aging Cell, breaks down the different methods scientists use to ...
10d
Hosted on MSNA cure for horse blindness could let humans see again tooResearch in horses may eventually lead to a treatment for people who develop blindness as a result of the autoimmune disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results